Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziad Khatib

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Brain Tumor Pathology|November 29, 2002
Molecular studies in pediatric medulloblastomasCheppail Ramachandran, Ziad Khatib, Enrique Escalon, et al.
Molecular Neurobiology|October 25, 2014
Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain TumorsBrenda Luna, Sanjiv Bhatia, Changwon Yoo, et al.
Journal of Molecular Neuroscience : MN|July 17, 2014
Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy numberBrenda Luna, Sanjiv Bhatia, Changwon Yoo, et al.
Advances in Radiation Oncology|August 19, 2021
Effect of Postoperative Radiation Therapy Timing on Survival in Pediatric and Young Adult EpendymomaSunny Shah, Kevin Gates, Chase Mallory, et al.
Journal of Neuro-Oncology|February 26, 2020
The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastomaFrederic A Vallejo, Sumedh S Shah, Nicolas de Cordoba, et al.
Journal of Neurosurgery. Pediatrics|April 6, 2019
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case reportMatthew D Hall, Yazmin Odia, Joshua E Allen, et al.
Cancers|May 4, 2026
Ex Vivo Characterization Studies Identify Candidate Therapies for the Individualized Care of <i>NF2</i>-Related SchwannomatosisEthan W Hass, Anna Nagel, Alexandra J Scott, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Nature Medicine|April 11, 2024
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersArlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Brain Tumor Pathology|November 29, 2002
Molecular studies in pediatric medulloblastomasCheppail Ramachandran, Ziad Khatib, Enrique Escalon, et al.
Molecular Neurobiology|October 25, 2014
Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain TumorsBrenda Luna, Sanjiv Bhatia, Changwon Yoo, et al.
Journal of Molecular Neuroscience : MN|July 17, 2014
Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy numberBrenda Luna, Sanjiv Bhatia, Changwon Yoo, et al.
Advances in Radiation Oncology|August 19, 2021
Effect of Postoperative Radiation Therapy Timing on Survival in Pediatric and Young Adult EpendymomaSunny Shah, Kevin Gates, Chase Mallory, et al.
Journal of Neuro-Oncology|February 26, 2020
The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastomaFrederic A Vallejo, Sumedh S Shah, Nicolas de Cordoba, et al.
Journal of Neurosurgery. Pediatrics|April 6, 2019
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case reportMatthew D Hall, Yazmin Odia, Joshua E Allen, et al.
Cancers|May 4, 2026
Ex Vivo Characterization Studies Identify Candidate Therapies for the Individualized Care of <i>NF2</i>-Related SchwannomatosisEthan W Hass, Anna Nagel, Alexandra J Scott, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Nature Medicine|April 11, 2024
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersArlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, et al.
Pageof 3